DHR vs WFC: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Wells Fargo & Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
Wells Fargo & Company · Financial Services
$81.52
+30.6% upside to fair value
Grade B
QuantHub Verdict
WFC has more upside to fair value
(+30.6%).
WFC trades at a lower forward P/E
(11.9x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
WFC |
| Current Price |
$174.04 |
$81.52 |
| Fair Value Estimate |
$197.01 |
$106.49 |
| Upside to Fair Value |
+13.2%
|
+30.6%
|
| Market Cap |
$123.2B |
$250.7B |
| Forward P/E |
33.4x
|
11.9x
|
| EV / EBITDA |
20.3x
|
16.7x
|
| Price / Sales |
5.0x
|
2.0x
|
| Price / FCF |
23.3x
|
-13.2x
|
| Revenue Growth YoY |
+3.7%
|
+7.3%
|
| Gross Margin |
60.7%
|
64.5%
|
| Operating Margin |
21.0%
|
20.5%
|
| Return on Equity |
7.1%
|
12.0%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.3%
|
—
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Wells Fargo & Company is a diversified financial services firm operating primarily in consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. The company benefits from a seasoned CEO with extensive industry experience and has made significant progress in regulatory compliance and operational efficiency, including lifting its asset cap in 2025.…
Accumulation Zones
| Metric |
DHR |
WFC |
| Zone Low |
$147.76 |
$79.87 |
| Zone High |
$167.46 |
$90.52 |
| In Buy Zone? |
No
|
Yes
|